期刊文献+

转化生长因子β1对肝癌细胞干性表型的调节作用 被引量:8

Transforming growth factor β1 inhibits the cancer stem-like phenotype in liver tumor cells
原文传递
导出
摘要 目的:探讨转化生长因子β1(transforming growth factorβ1,TGF-β1)体外对肝癌细胞干性特征的影响。方法:以转化H-ras的鼠肝肿瘤细胞LPC-H-ras和人肝癌细胞株PLC/PRF/5为研究对象,利用MTT法和多细胞球体培养法检测TGF-β1对肿瘤起始细胞增殖的抑制作用,FCM法检测细胞表面分子CD133的表达以及活性氧(reactive oxygen species,ROS)的水平;实时荧光定量PCR(real-time fluorogentic quantitative-PCR,RFQ-PCR)检测干细胞样基因的表达水平。结果:TGF-β1在体外能够改变LPC-H-ras细胞的形态并抑制细胞的生长;与未处理组相比,TGF-β1作用后,LPC-H-ras细胞表面CD133的表达降低,多细胞球体形成能力减弱,干细胞样基因的表达受到抑制;同样,在PLC/PRF/5细胞中,TGF-β1也能抑制CD133的表达、AFP基因表达以及多细胞球体的形成;另外,在LPC-H-ras细胞中,TGF-β1可诱导ROS表达升高,ROS的抑制剂N-乙酰半胱氨酸具有削弱TGF-β1诱导CD133表达下调的作用。结论:TGF-β1能够抑制肝癌起始细胞的增殖及干性,其作用机制可能与ROS表达上调有关。 Objective: To investigate the effect of transforming growth factor β1 (TGF-β1) on the stem-like phenotype of liver tumor cells in vitro. Methods: The inhibitory effects of TGF-β1 on the proliferation of liver tumor-initiating cells—mouse liver tumor cell LPC-H-ras and human liver tumor cell PLC/PRF/5 were evaluated by using MTT method and spheroid formation analysis. The expression of surface marker CD133 and reactive oxygen species (ROS) was detected by flow cytometry (FCM). The relative levels of stem-cell like genes were detected by real-time fluorogenic quantitative-PCR (RFQ-PCR). Results: TGF-β1 changed the morphology and inhibited the growth of LPC-H-ras cells in vitro. Compared with the untreated cells, the expression of CD133 in LPC-H-ras cells and their ability of spheroid formation induced by TGF-β1 were significantly decreased. In addition, the expressions of stem-cell like genes were inhibited after treatment with TGF-β1 in these cells. Similarly, the expression levels of CD133 and AFP mRNA and the spheroid formation ability were all down-regulated in PLC/PRF/5 cells treated with TGF-β1. Furthermore, the ROS level in LPC-H-ras cells mediated by TGF-β1 was increased, but it was decreased by using antioxidant N-acetylcysteine. Conclusion: TGF-β1 inhibits the proliferation and stem-like properties of mouse liver tumor-initiating cells by up-regulating ROS production.
出处 《肿瘤》 CAS CSCD 北大核心 2012年第4期227-233,共7页 Tumor
关键词 肝肿瘤 实验性 肿瘤干细胞 转化生长因子Β1 CD133 活性氧 Liver neoplasms experimental Neoplatic stem cell Transforming growth facter beta 1 CD133 Reactive oxgen species
  • 相关文献

参考文献24

  • 1SENTURK S,MUMCUOGLU M,GURSOY-YUZUGULLU O,et al.Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth[J].Hepatology,2010,52(3):966-974.
  • 2李琦,王炎,范忠泽,冯年平,高虹,南艺蕾,倪雷,鲍文磊,隋华.丹参酮ⅡA及其纳米粒诱导肝癌细胞凋亡及对p38MAPK、TGFβ1信号蛋白表达的影响[J].肿瘤,2008,28(1):8-12. 被引量:42
  • 3KAMINSKA B,WESOLOWSKA A,DANILKIEWICZ M.TGF beta signalling and its role in tumour pathogenesis[J].Acta Biochim Pol,2005,52(2):329-337.
  • 4WHARTON K,DERYNCK R.TGFbeta family signaling:novel insights in development and disease[J].Development,2009,136(22):3691-3697.
  • 5MASSAGUE J.TGF beta in cancer[J].Cell,2008,134(2):215-230.
  • 6ANIDO J,SAEZ-BORDERIAS A,GONZALEZ-JUNCA A,et al.TGF-beta receptor inhibitors target the CD44(high)/Id1(high)glioma-initiating cell population in human glioblastoma[J].Cancer Cell,2010,18(6):655-668.
  • 7DERYNCK R,AKHURST R J.Differentiation plasticity regulated by TGF-beta family proteins in development and disease[J].Nat Cell Biol,2007,9(9):1000-1004.
  • 8NAKA K,HOSHII T,MURAGUCHI T,et al.TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia[J].Nature,2010,463(7281):676-680.
  • 9SEOANE J.TGFbeta and cancer initiating cells[J].Cell Cycle,2009,8(23):3787-3788.
  • 10YOU H,DING W,ROUNTREE C B.Epigenetic regulation of cancer stem cell marker CD133by transforming growth factor-beta[J].Hepatology,2010,51(5):1635-1644.

二级参考文献8

共引文献41

同被引文献108

  • 1张烜,叶丽虹,张晓东.骨桥蛋白通过NF-κB上调钙蛋白酶小亚基1促进肝癌细胞迁移[J].生物化学与生物物理进展,2010,37(5):534-539. 被引量:5
  • 2邱大鹏,韩风,聂常富,周进学,蒙博.AFP-L3和AFP mRNA联合检测在肝癌治疗疗效观察和预后中的作用[J].中国老年学杂志,2014,34(10):2637-2638. 被引量:6
  • 3郜玉峰,李旭,谢琴秀,桂淑玉,汪渊,周青,李家斌,江晓平.骨桥蛋白和CD44v6在肝癌中的表达及意义[J].中华肝脏病杂志,2005,13(3):227-228. 被引量:16
  • 4崔澂,王润田.TGF-β介导的肿瘤免疫抑制研究及临床意义[J].实用肿瘤杂志,2005,20(5):457-460. 被引量:5
  • 5Carr BI, Kanke F, Wise M, et al. Clinical evaluation of lens culinaris agglutinin-reactive alpha-fetoprotein and des-gamma-carboxy pro- thrombin in histologically proven hepatocellular carcinoma in the U- nited States. Dig Dis, 2007,52 : 776-782.
  • 6Sterling RK, Jeffers L, Gordon F, et al. Utility of Lens culinaris ag- glutinin-reactive fraction of alpha-fetoprotein and des-gamma-car- boxy prothrombin, alone or in combination, as biomarkers for hepato- cellular carcinoma. Clin Gastroenterol Hepatol, 2009,7 : 104-1 13.
  • 7Mittal A, Gupta SP, Sathian B, et al. Des-gamma-carboxyprothrom- bin for early identification and prognosis of hepatocellular carcino- ma-a case control study from western Nepal. Asian Pac J Cancer Prey,2012,13 : 5773-5775.
  • 8Chon YE, Choi GH, Lee MH, et al. Combined measurement of pre-operative α-fetoprotein and des-γ-carboxy prothrombin predicts re- currence after curative resection in patients with hepatitis-B-related hepatocellular carcinoma. Int J Cancer, 2012,131 : 2332-2341.
  • 9Marrero JA, Su GL, Wet W, et al. Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients. Hepatology ,2003,37: 1 114-1121.
  • 10Filmus J, Capurro M. Glypican-3 : a marker and a therapeutic target in hepatoceUular carcinoma. FEBS J,2013,280 : 2471-2476.

引证文献8

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部